Production and Applications of Nicotine by Rundu International

Regulations by 2FIRSTS.ai
Oct.24.2023
Investors inquire about the nicotine purity and production capacity of Rundo International. The company replies that customization is available.

Recently, an investor inquired on an investor platform about the nicotine purity of Rundu Corporation (002923), the company's compliance with medical standards, as well as their nicotine production and primary customer base.

 

Rundu International responds to investors: Currently, Rundu International offers customized production based on customer needs, providing different purity levels of nicotine for various sectors including pharmaceuticals, pesticides, e-cigarettes, lozenges, and nicotine patches. The designed production capacity for the company's alkaloid (nicotine) project is 100 tons/year for plant extraction and purification processes, and 400 tons/year for chemical synthesis processes of alkaloids and intermediate products. The existing capacity is sufficient to meet sales demands. The company is actively exploring markets and adjusting production plans in a timely manner in accordance with local market access mechanisms.

 

Disclaimer: 
This article is translated from an original Chinese article available on 2firsts.cn by AI, and has been reviewed and edited by 2FIRSTS's English editorial team. The Chinese original text is the only authoritative source of information. The exclusive copyright and license rights to this article are held by 2FIRSTS Technology Co., Ltd. Any reproduction, reprinting, or redistribution of this article, either in part or in full, requires express written permission from 2FIRSTS and must include clear attribution along with a link to this content. Non-compliance may result in legal action. 2FIRSTS Technology Co., Ltd. reserves the right to pursue legal actions in case of unauthorized use or distribution.